Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 16550
Corporate User License Price USD 750
Corporate User License Price INR 49650
Site License Price USD 500
Site License Price INR 33100
Request a Quote

Report Title

Bellerophon Therapeutics Inc (BLPH)-Medical Equipment-Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Bellerophon Therapeutics Inc (BLPH)-Medical Equipment-Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Bellerophon Therapeutics Inc (BLPH)-Medical Equipment-Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Bellerophon Therapeutics Inc (BLPH)-Medical Equipment-Deals and Alliances Profile



Executive Summary

Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly known as Bellerophon Therapeutics LLC, is a clinical-stage biotherapeutics company which focuses on the development of products with the combination of drugs and devices for the treatment of cardiopulmonary diseases. The company pipeline portfolio offers product candidates for the treatment of pulmonary arterial hypertension (PAH), pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD), and pulmonary hypertension associated with idiopathic pulmonary fibrosis (PH-IPF). It develops products using INOpulse program, a proprietary pulsatile nitric oxide delivery device. Drugs candidates for the treatment of PAH and PH-COPD are in Phase III and Phase II clinical trials, respectively. Bellerophon Therapeutics is headquartered in Warren, New Jersey, the US.

Bellerophon Therapeutics Inc (BLPH)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Bellerophon Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Bellerophon Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Bellerophon Therapeutics Inc, Medical Equipment, Deal Details 10

Venture Financing 10

Bellerophon Therapeutics Raises Funds through Venture Financing 10

Bellerophon Therapeutics Secures USD80 Million in Venture Funding 10

Partnerships 11

Bellerophon Therapeutics Extends Licensing Agreement with INO Therapeutics 11

Bellerophon Amends Licensing Agreement with Ikaria 12

Equity Offering 13

Bellerophon Therapeutics to Raise USD30 Million in Private Placement of Shares 13

Bellerophon Therapeutics Raises USD12 Million in Public Offering of Shares 14

Bellerophon Therapeutics to Raise USD5.7 Million in Public offering of Shares 15

Bellerophon Therapeutics Raises USD60 Million in IPO 16

Bellerophon Therapeutics Inc-Key Competitors 18

Key Employees 19

Locations And Subsidiaries 20

Head Office 20

Recent Developments 21

Financial Announcements 21

May 15, 2017: Bellerophon Reports First Quarter 2017 Financial Results and Provides Business Update 21

Mar 13, 2017: Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update 23

Nov 08, 2016: Bellerophon Reports Third Quarter 2016 Financial Results and Provides Business Update 25

Aug 09, 2016: Bellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update 26

May 10, 2016: Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update 27

Mar 21, 2016: Bellerophon Reports 2015 Financial Results and Provides Business Update 28

Corporate Communications 30

Sep 20, 2016: Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016 30

Feb 23, 2016: Bellerophon Therapeutics Appoints Fabian Tenenbaum as Chief Financial Officer and Chief Business Officer 31

Feb 16, 2016: Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member 32

Legal and Regulatory 33

Mar 02, 2016: Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 33

Product News 34

Jan 21, 2016: Bellerophon Therapeutics Announces Notice of Intention to Grant a European Patent Supporting Its INOpulse Program 34

Jan 19, 2016: Bellerophon Therapeutics Receives EC Certification for New INOpulse Drug-Device Delivery System 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Bellerophon Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Bellerophon Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Bellerophon Therapeutics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

List of Tables

Bellerophon Therapeutics Inc, Medical Equipment, Key Facts, 2016 1

Bellerophon Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Bellerophon Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Bellerophon Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8

Bellerophon Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Bellerophon Therapeutics Raises Funds through Venture Financing 10

Bellerophon Therapeutics Secures USD80 Million in Venture Funding 10

Bellerophon Therapeutics Extends Licensing Agreement with INO Therapeutics 11

Bellerophon Amends Licensing Agreement with Ikaria 12

Bellerophon Therapeutics to Raise USD30 Million in Private Placement of Shares 13

Bellerophon Therapeutics Raises USD12 Million in Public Offering of Shares 14

Bellerophon Therapeutics to Raise USD5.7 Million in Public offering of Shares 15

Bellerophon Therapeutics Raises USD60 Million in IPO 16

Bellerophon Therapeutics Inc, Key Competitors 18

Bellerophon Therapeutics Inc, Key Employees 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Bellerophon Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand